UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934

                               (Amendment No. 1)

                   Committed Capital Acquisition Corporation
--------------------------------------------------------------------------------
                                (Name of Issuer)

                    Common Stock, par value $.0001 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   20261V 103
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                Philip Wagenheim
                      c/o Broadband Capital Management LLC
                          712 Fifth Avenue, 22nd Floor
                            New York, New York 10019
                                 (212) 277-5301
--------------------------------------------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                  May 27, 2011
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

     If the filing person has previously filed a statement on Schedule 13G to
     report the acquisition that is the subject of this Schedule 13D, and is
     filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or
     240.13d-1(g), check the following box. [ ]


     The information required on the remainder of this cover page shall not be
     deemed to be "filed" for the purpose of Section 18 of the Securities
     Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
     that section of the Act but shall be subject to all other provisions of the
     Act (however, see the Notes).



CUSIP No.   20261V 103
--------------------------------------------------------------------------------
              1. Names of Reporting Persons. I.R.S. Identification Nos. of above
                 persons (entities only).
                 Philip Wagenheim
--------------------------------------------------------------------------------
              2. Check the Appropriate Box if a Member of a Group (See
                 Instructions)
                 (a)
                 (b)
--------------------------------------------------------------------------------
              3. SEC Use Only
--------------------------------------------------------------------------------
              4. Source of Funds (See Instructions) (See item 3)  PF
--------------------------------------------------------------------------------
              5. Check if Disclosure of Legal Proceedings Is Required Pursuant
                 to Items 2(d) or 2(e)
--------------------------------------------------------------------------------
              6. Citizenship or Place of Organization
                 U.S.A.
--------------------------------------------------------------------------------
Number of          7. Sole Voting Power         638,316*
Shares           ---------------------------------------------------------------
Beneficially       8. Shared Voting Power
Owned by         ---------------------------------------------------------------
Each               9. Sole Dispositive Power    638,316*
Reporting        ---------------------------------------------------------------
Person With       10. Shared Dispositive Power
--------------------------------------------------------------------------------
             11. Aggregate Amount Beneficially Owned by Each Reporting Person
                 638,316*
--------------------------------------------------------------------------------
             12. Check if the Aggregate Amount in Row (11) Excludes Certain
                 Shares (See Instructions)
--------------------------------------------------------------------------------
             13. Percent of Class Represented by Amount in Row (11)
                 5.1%
--------------------------------------------------------------------------------
             14. Type of Reporting Person (See Instructions)
                 IN

____________
*     The  Issuer  effected a 4.21875-for-1 forward stock split on May 20, 2011.
      All  share amounts in this Schedule 13D have been adjusted to reflect such
      forward stock split.



                                Explanatory Note

      Except  as  specifically amended and supplemented by this Amendment No. 1,
all  other  provisions of the Schedule 13D filed by the Reporting Person on July
13,  2007  (the  "Original  Schedule  13D") remain in full force and effect. The
original  Schedule 13D together with this Amendment is referred to herein as the
"Schedule  13D."  Capitalized  terms used herein and not otherwise defined shall
have the same meanings ascribed to them in the Original Schedule 13D.

Item 1.  Security and Issuer.

      This  Schedule 13D relates to the common stock, par value $.0001 per share
(the  "Common  Stock"),  of  Committed  Capital  Acquisition  Corporation, whose
principal  executive  offices  are  located at 712 Fifth Avenue, 22nd Floor, New
York, New York 10019 (the "Issuer").

Item 4.  Purpose of Transaction.

      The  information provided or incorporated by reference in Item 5 is hereby
incorporated by reference in this Item 4.

Item 5.  Interest in Securities of the Issuer.

      This Amendment No. 1 amends and restates Item 5 of the Schedule 13D as set
forth below:

      (a)  The Reporting Person beneficially owns an aggregate of 638,316 shares
of  Common  Stock,  representing approximately 5.1% of the outstanding shares of
Common   Stock   (based   upon  12,500,000  shares  of  Common  Stock  currently
outstanding).

      (b)  The Reporting Person has the sole right to vote or dispose, or direct
the  voting  or  disposition  of,  all  of  the  638,316  shares of Common Stock
beneficially owned by the Reporting Person.

      (c)  On  May  20,  2011, the Issuer effected a 4.21875-for-1 forward stock
split,  upon  the  completion  of  which the Reporting Person beneficially owned
2,531,250  shares  of Common Stock, representing 37.5% of the outstanding shares
of  Common  Stock.  On  May  27, 2011, the Reporting Person entered into a Stock
Purchase  Agreement  with  P&P  2,  LLC  and Michael Serruya (the "Purchasers"),
pursuant  to which the Reporting Person sold an aggregate of 1,814,061 shares to
the  Purchasers.  Also,  on  May  27,  2011, the Reporting Person entered into a
Contribution  Agreement  with  Committed  Capital  Holdings LLC (the "Assignee")
pursuant to which the Reporting Person contributed an aggregate of 78,872 shares
of  Common  Stock  to the Assignee. The Reporting Person owns a 2.7% interest in
the  Assignee.  However, such shares owned by the Assignee are not considered to
be  beneficially owned by the Reporting Person because the Reporting Person does
not  have  voting or investment control over the shares of Common Stock owned by
the Assignee.

      On October 28, 2011, the Issuer completed its initial public offering (the
"Offering")  of  5,750,000  units  (the  "Units")  at  $5.00  per Unit for gross
proceeds  of  $28,750,000, which included the full exercise of the underwriters'
over-allotment  option.  The Reporting Person is the Secretary of the Issuer and
is a member of its board of directors.



      Each  Unit  consists  of  one  share  of  Common  Stock  and  one  warrant
("Warrant")  to purchase one share of Common Stock at an exercise price of $5.00
per  share.  Under  the  terms  of  the  warrant agreement pursuant to which the
Warrants  were  issued,  the Issuer has agreed to use its best efforts to file a
post-effective  amendment or new registration statement under the Securities Act
of 1933, as amended, to cover the shares of Common Stock underlying the Warrants
after  the completion of the Issuer's initial business transaction. Each Warrant
will  become  exercisable upon effectiveness of such post-effective amendment or
new registration statement and will expire 45 days from that effectiveness date.
However,  if the Issuer does not complete its initial business transaction on or
prior  to  the  21-month  or  24-month  period  allotted to complete its initial
business  transaction  (as described below), the Warrants will expire at the end
of such period.

      The  Issuer will have only 21 months from the date of effectiveness of the
registration  statement  for  the  Offering  (or  24  months  from  the  date of
effectiveness  of  such  registration  statement  if  a  letter  of  intent or a
definitive  agreement  has  been  executed  within  21  months  from the date of
effectiveness and the Issuer's business transaction relating thereto has not yet
been  completed  within such 21-month period) to consummate the initial business
transaction.

      The  Issuer's  initial  stockholders  (including  the  Reporting  Person),
together   with   certain  persons  that  may  be  designated  by  such  initial
stockholders  (the  "private  placement  investors"), have committed to purchase
2,000,000  shares of Common Stock (the "placement shares") at $5.00 per share in
a  private  placement  to  occur  concurrently  with the closing of the Issuer's
initial  business  transaction  for  gross proceeds of $10,000,000. The Issuer's
board  of  directors  will  have the ability to increase the size of the private
placement at its discretion.

      The  Issuer's  initial stockholders, private placement investors and their
permitted transferees will be entitled to registration rights. Such holders will
be  entitled to demand registration rights and certain "piggy-back" registration
rights  with  respect to the shares of Common Stock that they owned prior to the
Offering ("initial shares") and the placement shares, commencing, in the case of
the  initial  shares,  one  year  after the consummation of the Issuer's initial
business transaction and, in the case of the placement shares, 30 days after the
consummation of the Issuer's initial business transaction.

      All of the gross proceeds of the Offering equal to $28,750,000 were placed
in  a  trust account at JP Morgan Chase, N.A., with Continental Stock Transfer &
Trust  Company  acting  as  trustee. Except for a portion of the interest income
that may be released to the Issuer to pay income or other tax obligations and to
fund  its  working  capital  requirements,  none  of the funds held in the trust
account will be released until the earlier of (i) the consummation of a business
transaction,  (ii)  the  Issuer's  redemption  of  the public shares sold in the
Offering  if the Issuer is unable to consummate its initial business transaction
within  the  21-month  or 24-month period set forth above, or (iii) the Issuer's
liquidation (if no redemption occurs).



      As  a  result  of the transactions described above, as of the date of this
Amendment No. 1, the Reporting Person beneficially owns 638,316 shares of Common
Stock, representing approximately 5.1% of the outstanding shares of Common Stock
(based upon 12,500,000 shares of Common Stock currently outstanding).

      (d)  Other than the Reporting Person, no other person is known to have the
right  to  receive  or the power to direct the receipt of dividends from, or the
proceeds  from  the  sale  of, the shares of Common Stock owned by the Reporting
Person.

      (e) N/A.

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.

      The  information provided or incorporated by reference in Item 5 is hereby
incorporated by reference in this Item 6.


Item 7.  Material to Be Filed as Exhibits.

 EXHIBIT
 NUMBER     EXHIBIT
----------  --------------------------------------------------------------------

    1       Registration  Rights  Agreement,  dated  October  24,  2011,  by and
            between the Issuer and the stockholders listed on the signature page
            thereto  (filed  as Exhibit 10.2 to the Issuer's Form 8-K filed with
            the Commission on October 25, 2011).

    2       Form  of  Letter  Agreement  by  and  between the Issuer and each of
            Michael  Rapp, Philip Wagenheim and Jason Eiswerth (filed as Exhibit
            10.3  in  the  Issuer's  Registration  Statement  on  Form  S-1 (No.
            333-174599)).

    3       Form  of  Indemnity Agreement (filed as Exhibit 10.7 in the Issuer's
            Registration Statement on Form S-1 (No. 333-174599)).



Signature.

       After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


                                  November 1, 2011



                                  /s/ Philip Wagenheim
                                  --------------------
                                  Philip Wagenheim